If you want to get a "good return" on your investment (in both dollars and decency), look to adult stem cell research instead of companies experimenting with human embryos.
...Based in California, SmallCap Sentinel has been issuing investment information for 23 years and analyst D.R. Clark says adult stem cell research firms are a better buy.
"As the headline-grabbing battle regarding embryonic stem cell research rages, adult stem cell sources continue to provide an ever-broadening array of life-improving possibilities," Clark said in a statement LifeNews.com obtained.
"Researchers are using the far less controversial adult stem cells to attack enormous medical problems and are confident enough in their successes thus far to seek the protection of U.S. Patents," he added...
The rest of the story is here at LifeNews.com.
